Patents by Inventor Dzintra Muceniece

Dzintra Muceniece has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8680101
    Abstract: The invention relates to a pharmaceutical composition containing pimobendan as an active ingredient. The invention also relates to a crystalline form of pimobendan, as well as to a combination of said crystalline form with at least one other therapeutically active ingredient. Moreover, the invention relates to uses of said crystalline form, as well as to a pharmaceutical composition containing it. Finally, the invention relates to a process for preparing a crystalline form of pimobendan.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: March 25, 2014
    Assignee: Eurovet Animal Health B.V.
    Inventors: Marinus Maria Martinus Boeren, Rudolf Johannes Paridaans, Sanita Petkune, Viesturs Lusis, Dzintra Muceniece
  • Patent number: 8431717
    Abstract: The invention provides an improved, highly efficient method for preparing 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole, and its salts, in particular its pharmaceutically acceptable salts.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: April 30, 2013
    Assignee: JSC Grindeks
    Inventors: Viesturs Lusis, Dzintra Muceniece, Inese Reine, Armands Zandersons
  • Patent number: 8420807
    Abstract: The invention relates to a method for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo [b,f]-1,4-thiazepine and pharmaceutically acceptable salts thereof comprising the reaction of 1-[2-(hydroxyethoxy)-ethyl]piperazine with dibenzo[b,f][1,4]thiazepin-11-ylamine.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: April 16, 2013
    Assignee: Fermion Oy
    Inventors: Arne Grumann, Dzintra Muceniece, Otto Soidinsalo
  • Publication number: 20110152283
    Abstract: The invention relates to a pharmaceutical composition containing pimobendan as an active ingredient. The invention also relates to a crystalline form of pimobendan, as well as to a combination of said crystalline form with at least one other therapeutically active ingredient. Moreover, the invention relates to uses of said crystalline form, as well as to a pharmaceutical composition containing it. Finally, the invention relates to a process for preparing a crystalline form of pimobendan.
    Type: Application
    Filed: December 16, 2010
    Publication date: June 23, 2011
    Applicant: EUROVET ANIMAL HEALTH B.V.
    Inventors: Marinus Maria Martinus BOEREN, Rudolf Johannes PARIDAANS, Sanita PETKUNE, Viesturs LUSIS, Dzintra MUCENIECE
  • Publication number: 20110112290
    Abstract: The invention relates to a method for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine and pharmaceutically acceptable salts thereof comprising the reaction of 1-[2-(hydroxyethoxy)-ethyl]piperazine with dibenzo[b,f][1,4]thiazepin-11-ylamine.
    Type: Application
    Filed: January 30, 2009
    Publication date: May 12, 2011
    Applicant: FERMION OY
    Inventors: Arne Grumann, Dzintra Muceniece, Otto Soidinsalo
  • Publication number: 20110028733
    Abstract: The invention provides an improved, highly efficient method for preparing 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole, and its salts, in particular its pharmaceutically acceptable salts.
    Type: Application
    Filed: December 3, 2008
    Publication date: February 3, 2011
    Inventors: Viesturs Lusis, Dzintra Muceniece, Inese Reine, Armands Zandersons